Spartha Medical receives €2.4M in financing from EIC
Robocath concludes first European clinical study to demonstrate safety and efficacy of robotic coronary angioplasty performed with R-One
Study results will be presented at EuroPCR conference in Paris, France, May 2022
HypnoVR raises €4.5 million to accelerate the roll out of its digital therapy treating pain and anxiety
Series A funding round will allow company to accelerate international roll-out and extend scope of application of virtual reality-based medical hypnosis solution, used by healthcare professionals to treat pain and anxiety
Robocath successfully completes first robotic coronary angioplasty with R One in China
Robocath successfully performs first carotid stenting in France with R-ONE™ Robot at Rennes University Hospital
Genoskin appoints DR Nicolas Gaudenzio as chief scientific officer
World-renowned expert in immunology and allergic skin inflammation, Dr Nicolas Gaudenzio has just been appointed as CSO of ex vivo clinical testing specialist Genoskin. He also leads a research group at Inserm – the French National Institute of Health and Medical Research – in the field of skin neuro-immunology, inflammation and imaging
His expertise in skin immunology and imaging of the human immune system will guide Genoskin’s strategic shift towards immunology expert services for the pharmaceutical industry
Banook group acquires german counterpart Nabios gmbh to become a European leader in cardiac safety services
First external acquisition allows Banook Group to strengthen its presence in Central and Eastern Europe
Hephaï receives 2021 Catalyst Award from US National Academy of Medicine for its unique digital education platform
CARTHERA’S SonoCloud technology enhances the efficacy of immunotherapies for the treatment of brain tumors
Low Intensity Pulsed Ultrasound device can enhance delivery of CAR-T therapies and penetration of checkpoint inhibitors into the brain of preclinical glioma models; increasing probability of long-lasting immunity
